UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC  20549

                                  SCHEDULE 13G
                   UNDER THE SECURITIES EXCHANGE ACT OF 1934
                              (AMENDMENT NO. ___)*

                                 CLINICOR, INC.
                         ------------------------------
                                (Name of Issuer)

                    COMMON STOCK, PAR VALUE $.001 PER SHARE
                         ------------------------------
                         (Title of Class of Securities)

                                   18726M106
                         ------------------------------
                                 (CUSIP Number)


*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


CUSIP No.  18726M106
- --------------------------------------------------------------------------------

1.   Name of Reporting Person and S.S. or I.R.S. Identification Number

     Randolph J. Haag
- --------------------------------------------------------------------------------

2.   Check the Appropriate Row if a Member of a Group

     a.   N/A

     b.   N/A
- --------------------------------------------------------------------------------

                               Page 1 of 4 pages

 
3.   SEC Use Only

- --------------------------------------------------------------------------------

4.   Citizenship or Place of Organization

     U. S. citizen
- --------------------------------------------------------------------------------

     Number of Shares Beneficially Owned by Each Reporting Person With:

5.   Sole Voting Power      246,231 shares (see Item 4)

6.   Shared Voting Power      N/A

7.   Sole Dispositive Power    246,231 shares (see Item 4)

8.   Shared Dispositive Power    N/A
- --------------------------------------------------------------------------------

9.   Aggregate Amount Beneficially Owned by Each Reporting Person

     246,231 shares (see Item 4)
- --------------------------------------------------------------------------------

10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     N/A
- --------------------------------------------------------------------------------

11.  Percent of Class Represented by Amount in Row (9)

     5.9%
- --------------------------------------------------------------------------------

12.  Type of Reporting Person

     IN
- --------------------------------------------------------------------------------

                               Page 2 of 4 pages

 
ITEM 1(a).  NAME OF ISSUER:

            Clinicor, Inc.

ITEM 1(b).  ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

            1717 West Sixth Street, Suite 400
            Austin, Texas  78703

ITEM 2(a).  NAME OF PERSON FILING:

            Randolph J. Haag

ITEM 2(b).  ADDRESS OF PRINCIPAL BUSINESS OFFICE:

            2200 Leavenworth Street, #405
            San Francisco, California  94133

ITEM 2(c).  CITIZENSHIP/STATE OF ORGANIZATION:

            U.S. citizen

ITEM 2(d).  TITLE OF CLASS OF SECURITIES:

            Common Stock, par value $.001 per share

ITEM 2(e).  CUSIP NUMBER:

            18726M106

ITEM 3.     FILING PURSUANT TO RULE 13d-1(b):

            N/A

ITEM 4.     OWNERSHIP:

            (a) Amount Beneficially Owned:  246,231 shares

            (b) Percent of Class:  5.9%

            (c) Number of shares as to which such person has:

                (i)   sole power to vote or direct the vote:  246,231 shares

                (ii)  shared power to vote or to direct the vote:  N/A

               (iii)  sole power to dispose or to direct the disposition of:
                      246,231 shares

                               Page 3 of 4 pages

 
               (iv)   shared power to dispose or to direct the disposition of:
                      N/A

            Note: The 246,231 shares of Common Stock beneficially owned by 
            Mr. Haag include (1) 50,000 shares issuable to Mr. Haag pursuant to
            immediately exercisable options and (2) 51,606 shares issuable to
            Mr. Haag pursuant to immediately exercisable sales agent warrants.

ITEM 5.     OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

            N/A

ITEM 6.     OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

            N/A

ITEM 7.     IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED 
            THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

            N/A

ITEM 8.     IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

            N/A

ITEM 9.     NOTICE OF DISSOLUTION OF GROUP:

            N/A

ITEM 10.    CERTIFICATION:

            N/A


                                   SIGNATURE

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Section 13G is true, complete and
correct.



Dated:  February 10, 1998           /s/  Randolph J. Haag 
        -----------------           ----------------------------------------
                                    Randolph J. Haag


                               Page 4 of 4 pages